Products Categories
| CAS No.: | 38562-01-5 |
|---|---|
| Name: | Prostaglandin F2a tris salt |
| Article Data: | 11 |
| Molecular Structure: | |
|
|
|
| Formula: | C20H34O5.C4H11NO3 |
| Molecular Weight: | 475.623 |
| Synonyms: | 2-amino-2-(hydroxymethyl)propane-1,3-diol; (E)-7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid;Panacelan F tromethamine salt;Enzaprost F compd. with trisamine;Dinoprost tromethamine (JAN/USP);Prostaglandin F2.alpha., compd. with 2-amino-2-hydroxymethyl-1,3-propanediol (1:1);Dinoprost tromethamine;7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid, tromethamine salt;Prosta-5,13-dien-1-oic acid, (5Z,9.alpha.,11.alpha.,13E,15S)-9,11,15-trihydroxy- compd. with (trimethylolamino)methane;Prosta-5,13-dien-1-oic acid, 9,11, 15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1);Ensaprost;Pronalgon F;Prosta-5,13-dien-1-oic acid,9,11,15-trihydroxy-,(5Z,9R,11R,13E,- 15S)-,compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1);Zinoprost;Dinoprost Trometamol; |
| EINECS: | 254-002-3 |
| Melting Point: | 25-35oC |
| Boiling Point: | 531 °C at 760 mmHg |
| Flash Point: | 289 °C |
| Solubility: | H2O: 1 mg/mL |
| Hazard Symbols: |
 T
|
| Risk Codes: | 60-22 |
| Safety: | 53-45 |
| PSA: | 184.70000 |
| LogP: | 1.40400 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- 43224-75-52,2,6,6-Tetramethyl-4-(2-propyleneoxy) Piperidine
- 9000-40-2Carob gum
- 863288-34-0CJC 1295
- 877-22-5Benzoic acid,2-hydroxy-3-methoxy-
- 144-83-2Benzenesulfonamide,4-amino-N-2-pyridinyl-
- 41162-19-0Phosphonic acid,P-(2-oxo-4-phenylbutyl)-, dimethyl ester
- 20633-67-4Calycosin-7-O-beta-D-glucoside
- 5188-07-8Methanethiol, sodiumsalt (1:1)
- 13731-82-31,4-Benzenedicarboxylicacid, 2,5-dibromo-
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
The Prostaglandin F2a tris salt, with the CAS registry number 38562-01-5, is also known as Panacelan F tromethamine salt. Its EINECS registry number is 254-002-3. This chemical's molecular formula is C24H45NO8 and molecular weight is 475.62. Its IUPAC name is called 2-amino-2-(hydroxymethyl)propane-1,3-diol; 7-[3,5-dihydroxy-2-(3-hydroxyoct-1-enyl)cyclopentyl]hept-5-enoic acid. The product should be sealed at temperature of -18 °C. This chemical's classification code ares Abortifacient Agents; Abortifacient agents, nonsteroidal; Human Data; Oxytocic; Oxytocics; Prostaglandin; Reproductive Control Agents; Reproductive Effect.
Physical properties of Prostaglandin F2a tris salt: (1)ACD/LogP: 2.14; (2)ACD/LogD (pH 5.5): 1.33; (3)ACD/LogD (pH 7.4): -0.47; (4)ACD/BCF (pH 5.5): 3.86; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 53.76; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 5; (9)#H bond donors: 4; (10)#Freely Rotating Bonds: 15; (11)Flash Point: 289 °C; (12)Enthalpy of Vaporization: 92.76 kJ/mol; (13)Boiling Point: 531 °C at 760 mmHg; (14)Vapour Pressure: 1.71E-13 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
This chemicals that at low levels can cause damage to health. It is harmful if swallowed. Besides, it may impair fertility. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible). What's more, it must be avoid exposure - obtain special instructions before use.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O
(2)InChI: InChI=1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2
(3)InChIKey: IYGXEHDCSOYNKY-UHFFFAOYSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intramuscular | 111mg/kg (111mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 21, Pg. 623, 1974. |
| mouse | LD50 | intraperitoneal | 101mg/kg (101mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 21, Pg. 623, 1974. |
| mouse | LD50 | intravenous | 331mg/kg (331mg/kg) | Drugs in Japan Vol. 6, Pg. 327, 1982. | |
| mouse | LD50 | oral | 711mg/kg (711mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 21, Pg. 623, 1974. |
| mouse | LD50 | subcutaneous | 214mg/kg (214mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 21, Pg. 623, 1974. |
| rat | LD50 | intramuscular | 59mg/kg (59mg/kg) | Drugs in Japan Vol. 6, Pg. 327, 1982. | |
| rat | LD50 | intraperitoneal | 101mg/kg (101mg/kg) | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 22, Pg. 517, 1975. | |
| rat | LD50 | intravenous | 101mg/kg (101mg/kg) | Drugs in Japan Vol. 6, Pg. 327, 1982. | |
| rat | LD50 | oral | 665mg/kg (665mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Yakkyoku. Pharmacy. Vol. 32, Pg. 1129, 1981. |
| rat | LD50 | subcutaneous | 66mg/kg (66mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 21, Pg. 623, 1974. |